IQVIA

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

The power of R&D collaborations to improve outcomes in rare ...

Far more common than initially thought, rare disease treatments remain far too scarce.

News

Achieving patient centricity in a digital health world

Around 250 digital health apps are launching every day, says...

There was a dramatic increase in the launch of health-related mobile applications last year, taking the total number on offer in app stories to 350,000 – and while average quality is curren

Views & Analysis

Surprise pandemic lessons for pharma

Ask people in most western nations to think back to 2019 and consider what they would have said then about the potential impact of a pandemic on their everyday lives and my guess is that th

Views & Analysis

Designing HCP engagement for the next normal

Life sciences companies’ engagement with HCPs has changed significantly in the past 12 months, as the COVID-19 pandemic struck.

Views & Analysis

Research predicts the post-COVID landscape for HCP engagemen...

IQVIA’s Liz Murray takes us through the company’s latest research into HCPs’ attitudes to pharma engagement, and asks how pharma sales forces can adapt for future changes.

Views & Analysis

A year on: pandemic driven trends in HCP engagement

IQVIA’s John Procter explores why the industry should be paying attention to the changing HCP customer experience in the wake of COVID-19.

The power of R&D collaborations to improve outcomes in rare ...

Around 250 digital health apps are launching every day, says...

Surprise pandemic lessons for pharma

Designing HCP engagement for the next normal

Research predicts the post-COVID landscape for HCP engagemen...

A year on: pandemic driven trends in HCP engagement

Setback for MSD as German court blocks Keytruda SC launch

How to meet your physicians where they are online

IQVIA

Editor's Picks